MARX Biotech Co (ROCO:7731) ROCE % : -37.52% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is MARX Biotech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MARX Biotech Co's annualized ROCE % for the quarter that ended in Jun. 2024 was -37.52%.

MARX Biotech Co ROCE % Historical Data

The historical data trend for MARX Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MARX Biotech Co ROCE % Chart

MARX Biotech Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

26.61

7.83

-8.50

MARX Biotech Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial			-11.05	28.19	4.82	-15.89	-37.52

MARX Biotech Co ROCE % Calculation

MARX Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-15.116	/	( ( (103.186 - 41.503)	+	(394.847 - 101.036) )	/ 2 )
	=	-15.116	/	( (61.683	+	293.811)	/ 2 )
	=	-15.116	/	177.747
	=	-8.50 %

MARX Biotech Co's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-101.782	/	( ( (394.847 - 101.036)	+	(413.459 - 164.694) )	/ 2 )
	=	-101.782	/	( ( 293.811	+	248.765 )	/ 2 )
	=	-101.782	/	271.288
	=	-37.52 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

MARX Biotech Co (ROCO:7731) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MARX Biotech Co ROCE % Related Terms

Thank you for viewing the detailed overview of MARX Biotech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

MARX Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MARX Biotech Co Ltd (ROCO:7731) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN

Website

https://www.marxbiotech.com

MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.

MARX Biotech Co Headlines

No Headlines